Articles from Entrada Ventures Group

ELLA™ Receives Independent IRB Exemption Determination, Setting a New Standard for Ethical AI in Clinical Research
SOGLIA™, the Patient Experience Organization (PXO) redefining how people connect with clinical trials, today announced that ELLA™, its emotionally intelligent AI health advocate built on the E1™ orchestration platform, has received an independent Institutional Review Board (IRB) exemption determination under federal guidelines, affirming its ability to ethically support clinical research through informational outreach and participant prescreening.
By Entrada Ventures Group · Via Business Wire · February 26, 2026